For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink ...
The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback